富血小板血浆与皮质类固醇注射治疗足底筋膜炎:系统综述与荟萃分析
该系统综述与荟萃分析纳入15项1级和2级研究,比较病灶内注射富血小板血浆(PRP)与皮质类固醇治疗足底筋膜炎的疗效。美国足踝外科协会评分在1个月(P=.4)和3个月(P=.076)无显著差异,6个月(P=.009)和12个月(P=.009)PRP显著更优;视觉模拟疼痛评分在1个月(P=.653)无显著差异,3个月(P=.0001)、6个月(P=.002)和12个月(P=.019)PRP显著更优。作者认为PRP在3个月时疼痛控制优于皮质类固醇并持续至1年,但研究质量低、偏倚风险高及PRP制备方案不同降低了结论的内部和外部有效性,需谨慎看待。
要点
- 美国足踝外科协会评分:1个月(P=.4)和3个月(P=.076)无显著差异,6个月(P=.009)和12个月(P=.009)PRP显著优于皮质类固醇。
- 视觉模拟疼痛评分:1个月(P=.653)无显著差异,3个月(P=.0001)、6个月(P=.002)和12个月(P=.019)PRP显著更优。
- 作者结论认为PRP在3个月时疼痛控制优于皮质类固醇并持续至1年,但研究质量低、偏倚风险高及PRP制备方案不同,需谨慎看待。
核心结论
- 作者结论认为PRP在3个月时疼痛控制优于皮质类固醇注射,并持续至1年;短期皮质类固醇注射无优势。
- 作者指出研究质量低、偏倚风险高及PRP制备方案不同降低了结论的内部和外部有效性,结果需谨慎看待。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase、Scopus和Google Scholar,纳入2010年至2019年所有1级和2级研究。
- 共纳入15项研究,采用美国足踝外科协会评分和视觉模拟疼痛评分作为结局变量。
- 采用Cochrane协作工具评估发表偏倚和偏倚风险,采用推荐分级的评估、制定与评价系统评估证据体质量,采用χ2和I2统计量评估异质性。
主要发现
- 共纳入15项研究,其中9项存在高偏倚风险;1项高质量、9项中等质量、2项低质量、3项极低质量。
- 美国足踝外科协会评分合并估计:1个月(P=.4)和3个月(P=.076)差异无统计学意义,6个月(P=.009)和12个月(P=.009)差异有统计学意义,支持PRP。
- 视觉模拟疼痛评分合并估计:1个月(P=.653)差异无统计学意义,3个月(P=.0001)、6个月(P=.002)和12个月(P=.019)差异有统计学意义,支持PRP。
关键数值与推荐
- 美国足踝外科协会评分:1个月P=.4、3个月P=.076(无显著差异),6个月P=.009、12个月P=.009(PRP显著更优)。
- 视觉模拟疼痛评分:1个月P=.653(无显著差异),3个月P=.0001、6个月P=.002、12个月P=.019(PRP显著更优)。
- 证据质量:1项高质量、9项中等质量、2项低质量、3项极低质量;9项研究存在高偏倚风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 低研究质量、高偏倚风险和不同的PRP制备方案降低了这些发现的内部和外部有效性,这些结果必须谨慎看待。
- 9项研究存在高偏倚风险;证据质量方面1项高质量、9项中等质量、2项低质量、3项极低质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Plantar fasciitis is a common cause of heel pain. Corticosteroid injections are commonly used and proven to be effective, and lately platelet-rich plasma (PRP) has been used with mixed results. PURPOSE: To perform a systematic review and meta-analysis comparing intralesional injections of PRP and steroid infiltration. STUDY DESIGN: Systematic review and meta-analysis. METHODS: A systematic review of Medline, Embase, Scopus, and Google Scholar including all level 1 and 2 studies from 2010 to 2019 was perfomed. American Orthopaedic Foot and Ankle Society and visual analog scale for pain scores were used as outcome variables. Publication bias and risk of bias was assessed with the Cochrane Collaboration tools. The Grading of Recommendations, Assessment, Development and Evaluations system was used to assess the quality of the body of evidence. Heterogeneity was assessed with χ2 and I2 statistics. RESULTS: Fifteen studies were included in the analysis. Nine studies had a high risk of bias. There was 1 study with high quality, 9 with moderate, 2 studies with low, and 3 with very low quality. The pooled estimate for the American Orthopaedic Foot and Ankle Society score demonstrated nonsignificant differences at 1 month (P = .4) and 3 months (P = .076). At 6 months (P = .009) and 12 months (P = .009), it indicated significant differences in favor of PRP. The pooled estimate for visual analog scale demonstrated nonsignificant differences at 1 month (P = .653). At 3 months (P = .0001), 6 months (P = .002), and 12 months (P = .019), it yielded significant differences in favor of PRP. CONCLUSION: The results of this systematic review and meta-analysis suggest that PRP is superior to corticosteroid injections for pain control at 3 months and lasts up to 1 year. In the short term, there is no advantage of corticosteroid infiltration. However, the low study quality, high risk of bias, and different protocols for PRP preparation reduce the internal and external validity of these findings, and these results must be viewed with caution.
引用
- Hohmann E, Tetsworth K, Glatt V, et al. Platelet-Rich Plasma Versus Corticosteroids for the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis. Am J Sports Med. 2020. PMID: 32822236. doi:10.1177/0363546520937293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。